US Government Weighs Equity Injection in Intel

Mace | 15th August 2025 | International, Washington
1741897325096

The US government is considering taking a stake in Intel using Chips Act funds, boosting the company’s share price. Talks follow recent tensions between the president and Intel’s chief executive. No deal has been confirmed, and the White House calls the reports speculative. The move could expand state involvement in technology.

The US government is reportedly exploring the possibility of purchasing a stake in Intel as part of a broader push to strengthen domestic semiconductor manufacturing. Chips Act funds are under consideration for this purpose. Intel shares reacted positively to the news, gaining around four per cent on one exchange and higher on others, producing significant mid-week rises. The discussions follow a White House meeting earlier this week between the president and Intel’s chief executive. This came after public criticism of the executive’s ties to Chinese technology interests. A deal would mark a departure from previous forms of government assistance to the chipmaker, such as subsidies and tax incentives under the Chips and Science Act. It could represent a more direct form of state involvement. Intel has faced challenges in building momentum for its Ohio semiconductor facility. The project has suffered delays and scaling back of construction due to demand-based strategy adjustments. The potential government stake could provide the company with financial breathing room. This may help revive its foundry operations and support competition with rivals in advanced chip technology. No agreement has been confirmed. The White House has described the reports as speculative, and both parties have declined to issue official statements. Analysts note that this would represent a new model of engagement between government and private industry. It could reshape policy expectations for strategic technology sectors. Reports highlight the increasingly transactional nature of state-industry relations in the semiconductor sector. Similar interventions have taken place in areas such as rare earths and AI chip regulation. Intel’s leadership change earlier this year adds further context to the talks. The newly appointed chief executive is steering efforts under scrutiny and pressure from investors. Observers are watching closely to see whether the level of federal commitment will be formalised. Any deal could shape Intel’s foundry ambitions and influence the global semiconductor landscape....

Subscribe to The Mace

Join the member community shaping British politics and stay ahead of what's really happening in the world of politics and public affairs, with expert analysis, breaking news, and insider insights from Westminster and Brussels. The Mace is the leading news source and resource for the government affairs industry, offering required reading and lobby intelligence for professionals.

To see what you are missing out on by not subscribing to The Mace, click here to download our full membership info-pack. This includes having no paywall on op-ed content or profiles/interviews, allowing professional profiles to be read with maximum impact and visibility by government, special advisers, MPs, peers, civil servants, and policy and political decision-makers.

Merkel’s Legacy is in Tatters

Azeem Ibrahim OBE | June 30, 2026

How Angela Merkel Weakened the West and Handed Putin and Xi Leverage

‘Never bet against America’ SpaceX debut makes millions for the UK  

Lucy Carrier-Pilkington | June 16, 2026

The most highly anticipated stock market debut of the year, perhaps of all time, has delivered a huge win for UK investors.

Checkmate DC’s bold London move

William Cash | June 5, 2026

Tristan Breijer is the new London head of Checkmate Government Relations. The move into London gives the US lobby firm its first European base, bringing its global power-broking

EU likely to shelve chemical reform amid industry pressure 

Lucy Carrier-Pilkington | May 6, 2026

The reform concerns a pre-existing law on the Regulation, Authorisation and Restriction of Chemicals (REACH) and has been in place since June 2007.  

King Charles: The real ‘special ingredient’ in our relationship with the USA 

Lucy Carrier-Pilkington | April 29, 2026

King Charles’s address to Congress was designed to steady a strained special relationship. Twelve standing ovations later, the Palace had given Downing Street something politics could not: a

Pagefield and WPI’s merger throws into question the boutique PA firm model

Mace | March 26, 2026

As the two firms face a merger, the question over the longevity of the boutique firm is put under the spotlight.

Maritime trade bodies warn of citizens being caught in Iranian crossfire

Oliver Dean | March 12, 2026

As the Iranian conflict continues, maritime trade bodies have warned of the significant loss of human life thus far.

Britain faces a crisis of statecraft – not power.

Azeem Ibrahim OBE | March 9, 2026

Despite being criticised for its dwindling position on the world stage, Britain is not lacking in power. What it really needs is statesmanship.

US defence industry launches lobbying offensive against EU’s ‘Buy European’ push

Oliver Dean | February 20, 2026

As European policymakers push a 'Buy European' line, lobbyists and officials in Washington are keen to maintain dominance over the European arms market

Hanbury goes global

Oliver Dean | February 13, 2026

Hanbury's decision to erect offices in Washington and Sydney showcases the firms' strong public image.